MacroGenics, Inc.

MGNX Stock Healthcare Biotechnology
$3.25
-0.12 (-3.56%)
Price as of Oct 16, 2026 market close

Performance

1 Month
-21.3%
3 Months
-24.8%
YTD
+101.9%
1 Year
+92.3%
3 Year annualized
-14.3%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
86.0%
Largest decline max drawdown, since Oct 2021
-95.2%
Risk-adjusted return Sharpe ratio, 1-year
1.15

Own MGNX?

See how MGNX contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.